Vaccinex (VCNX) Tops Q1 EPS by 20c

Vaccinex (NASDAQ: VCNX) reported Q1 EPS of ($0.10), $0.20 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $550 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Vaccinex (VCNX) click here.

You May Also Be Interested In

• Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
• Redwood Trust prices $185M convertible notes due 2030
• Copart (CPRT) Misses Q4 EPS by 4c